Nektar Therapeutics News

Nektar Therapeutics | ARS: Annual Report to Security Holders

Apr 27 10:29

Nektar Therapeutics | DEFA14A: Others

Apr 27 04:29

Nektar Therapeutics | DEF 14A: Definitive information statements

Apr 27 04:18

Nektar Therapeutics | 8-K: Current report

Apr 18 05:05

Nektar Therapeutics | D: Filing D

Mar 20 04:42

Nektar Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-TCG Crossover GP II, LLC(9.9%),TCG Crossover Fund II, L.P.(9.9%), etc.

Mar 16 04:27

Nektar Therapeutics | 3: Initial statement of beneficial ownership of securities-10% Owner Deep Track Capital, LP

Mar 15 04:37

Nektar Therapeutics | 10-K: Annual report

Mar 6 06:16

Nektar Therapeutics | 8-K: Nektar Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results

Mar 5 05:26

Nektar Therapeutics | 8-K: Current report

Mar 4 21:45

Nektar Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Zalevsky Jonathan

Feb 23 09:23

Nektar Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Wilson Mark Andrew

Feb 23 09:23

Nektar Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer ROBIN HOWARD W

Feb 23 09:18

Nektar Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Feb 21 04:59

Nektar Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Feb 21 04:54

Nektar Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Feb 21 04:54

Nektar Therapeutics | 8-K: Current report

Feb 17 06:19

Nektar Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(0%),Peter Kolchinsky(0%), etc.

Feb 15 06:10

Nektar Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Citadel Advisors LLC(3.0%),Citadel Advisors Holdings LP(3.0%), etc.

Feb 15 06:05

Nektar Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Deep Track Capital, LP(9.65%),Deep Track Biotechnology Master Fund, Ltd.(9.65%), etc.

Feb 14 21:58